1	state	_	State	_	NNP	1	_	_	_	_	_	_	_	O
2	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
3	drug	_	drug	_	NN	1	_	_	_	_	_	drug.n	Cause_harm	O
4	monitoring	_	monitoring	_	NN	1	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	1	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	1	_	_	_	_	_	_	_	O
7	promising	_	promise	_	VBG	1	_	_	_	_	_	_	_	O
8	tools	_	tool	_	NNS	1	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
10	rein	_	rein	_	VB	1	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
13	epidemic	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
15	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
16	opioid	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	overdose	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	state	_	State	_	NNP	1	_	_	_	_	_	_	_	O
2	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
3	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
4	monitoring	_	monitoring	_	NN	1	_	_	_	_	_	monitoring.n	Scrutiny	O
5	programs	_	program	_	NNS	1	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	1	_	_	_	_	_	_	_	O
7	promising	_	promise	_	VBG	1	_	_	_	_	_	_	_	O
8	tools	_	tool	_	NNS	1	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
10	rein	_	rein	_	VB	1	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
13	epidemic	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
15	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
16	opioid	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	overdose	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	state	_	State	_	NNP	1	_	_	_	_	_	_	_	O
2	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
3	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
4	monitoring	_	monitoring	_	NN	1	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	1	_	_	_	_	_	program.n	Project	O
6	are	_	be	_	VBP	1	_	_	_	_	_	_	_	O
7	promising	_	promise	_	VBG	1	_	_	_	_	_	_	_	O
8	tools	_	tool	_	NNS	1	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
10	rein	_	rein	_	VB	1	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
13	epidemic	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
15	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
16	opioid	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	overdose	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	state	_	State	_	NNP	1	_	_	_	_	_	_	_	O
2	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
3	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
4	monitoring	_	monitoring	_	NN	1	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	1	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	1	_	_	_	_	_	_	_	O
7	promising	_	promise	_	VBG	1	_	_	_	_	_	_	_	O
8	tools	_	tool	_	NNS	1	_	_	_	_	_	tool.n	Gizmo	O
9	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
10	rein	_	rein	_	VB	1	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
13	epidemic	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
15	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
16	opioid	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	overdose	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	state	_	State	_	NNP	1	_	_	_	_	_	_	_	O
2	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
3	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
4	monitoring	_	monitoring	_	NN	1	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	1	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	1	_	_	_	_	_	_	_	O
7	promising	_	promise	_	VBG	1	_	_	_	_	_	_	_	O
8	tools	_	tool	_	NNS	1	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	1	_	_	_	_	_	to.prep	Goal	O
10	rein	_	rein	_	VB	1	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
13	epidemic	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
15	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
16	opioid	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	overdose	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	state	_	State	_	NNP	1	_	_	_	_	_	_	_	O
2	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
3	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
4	monitoring	_	monitoring	_	NN	1	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	1	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	1	_	_	_	_	_	_	_	O
7	promising	_	promise	_	VBG	1	_	_	_	_	_	_	_	O
8	tools	_	tool	_	NNS	1	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
10	rein	_	rein	_	VB	1	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
13	epidemic	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	1	_	_	_	_	_	of.prep	Age	O
15	prescription	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
16	opioid	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	overdose	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	use.v	Ingest_substance	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	from.prep	Evidence	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	national.a	Political_locales	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	to.prep	Goal	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	assess.v	Assessing	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	effect.n	Being_in_effect	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	of.prep	Age	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	program.n	Project	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	of.prep	Age	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	other.a	Increment	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	care.v	Desiring	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	of.prep	Age	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	care.v	Desiring	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	from.prep	Evidence	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	2	_	_	_	_	_	_	_	O
2	used	_	use	_	VBD	2	_	_	_	_	_	_	_	O
3	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
4	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
6	national	_	national	_	JJ	2	_	_	_	_	_	_	_	O
7	survey	_	survey	_	NN	2	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	2	_	_	_	_	_	_	_	O
9	assess	_	assess	_	VB	2	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	2	_	_	_	_	_	_	_	O
12	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
13	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
14	programs	_	program	_	NNS	2	_	_	_	_	_	_	_	O
15	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
17	prescribing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
19	opioid	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
20	analgesics	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
22	other	_	other	_	JJ	2	_	_	_	_	_	_	_	O
23	pain	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
24	medications	_	medication	_	NNS	2	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
26	ambulatory	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
28	settings	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
29	at	_	at	_	IN	2	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
31	point	_	point	_	NN	2	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
33	care	_	care	_	NN	2	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
35	twenty-four	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
36	states	_	state	_	NNS	2	_	_	_	_	_	_	_	O
37	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
38	2001	_	2001	_	CD	2	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	2	_	_	_	_	_	to.prep	Goal	O
40	2010	_	2010	_	CD	2	_	_	_	_	_	_	_	O
41	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	find.v	Coming_up_with	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	that.adv	Degree	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	implementation.n	Execute_plan	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	of.prep	Age	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	drug.n	Cause_harm	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	monitoring.n	Scrutiny	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	associate.v	Collaboration	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	more.a	Increment	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	reduction.n	Cause_expansion	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	rate.n	Speed_description	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	of.prep	Age	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	3	_	_	_	_	_	_	_	O
2	found	_	find	_	VBD	3	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	implementation	_	implementation	_	NN	3	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	prescription	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
10	monitoring	_	monitoring	_	NN	3	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	3	_	_	_	_	_	_	_	O
12	was	_	be	_	VBD	3	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	3	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
15	more	_	more	_	JJR	3	_	_	_	_	_	_	_	O
16	than	_	than	_	IN	3	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
18	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
19	percent	_	percent	_	NN	3	_	_	_	_	_	_	_	O
20	reduction	_	reduction	_	NN	3	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	prescribing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	3	_	_	_	_	_	of.prep	Age	O
27	schedule	_	Schedule	_	NNP	3	_	_	_	_	_	_	_	O
28	ii	_	II	_	NNP	3	_	_	_	_	_	_	_	O
29	opioids	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
30	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	4	_	_	_	_	_	_	_	O
2	reduction	_	reduction	_	NN	4	_	_	_	_	_	reduction.n	Cause_expansion	O
3	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
4	seen	_	see	_	VBN	4	_	_	_	_	_	_	_	O
5	immediately	_	immediately	_	RB	4	_	_	_	_	_	_	_	O
6	following	_	follow	_	VBG	4	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
8	launch	_	launch	_	NN	4	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	4	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
13	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
14	maintained	_	maintain	_	VBN	4	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
17	second	_	second	_	JJ	4	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
19	third	_	third	_	JJ	4	_	_	_	_	_	_	_	O
20	years	_	year	_	NNS	4	_	_	_	_	_	_	_	O
21	afterward	_	afterward	_	RB	4	_	_	_	_	_	_	_	O
22	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	4	_	_	_	_	_	_	_	O
2	reduction	_	reduction	_	NN	4	_	_	_	_	_	_	_	O
3	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
4	seen	_	see	_	VBN	4	_	_	_	_	_	see.v	Perception_experience	O
5	immediately	_	immediately	_	RB	4	_	_	_	_	_	_	_	O
6	following	_	follow	_	VBG	4	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
8	launch	_	launch	_	NN	4	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	4	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
13	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
14	maintained	_	maintain	_	VBN	4	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
17	second	_	second	_	JJ	4	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
19	third	_	third	_	JJ	4	_	_	_	_	_	_	_	O
20	years	_	year	_	NNS	4	_	_	_	_	_	_	_	O
21	afterward	_	afterward	_	RB	4	_	_	_	_	_	_	_	O
22	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	4	_	_	_	_	_	_	_	O
2	reduction	_	reduction	_	NN	4	_	_	_	_	_	_	_	O
3	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
4	seen	_	see	_	VBN	4	_	_	_	_	_	_	_	O
5	immediately	_	immediately	_	RB	4	_	_	_	_	_	_	_	O
6	following	_	follow	_	VBG	4	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
8	launch	_	launch	_	NN	4	_	_	_	_	_	launch.n	Reshaping	O
9	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	4	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
13	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
14	maintained	_	maintain	_	VBN	4	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
17	second	_	second	_	JJ	4	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
19	third	_	third	_	JJ	4	_	_	_	_	_	_	_	O
20	years	_	year	_	NNS	4	_	_	_	_	_	_	_	O
21	afterward	_	afterward	_	RB	4	_	_	_	_	_	_	_	O
22	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	4	_	_	_	_	_	_	_	O
2	reduction	_	reduction	_	NN	4	_	_	_	_	_	_	_	O
3	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
4	seen	_	see	_	VBN	4	_	_	_	_	_	_	_	O
5	immediately	_	immediately	_	RB	4	_	_	_	_	_	_	_	O
6	following	_	follow	_	VBG	4	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
8	launch	_	launch	_	NN	4	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	4	_	_	_	_	_	of.prep	Age	O
10	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	4	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
13	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
14	maintained	_	maintain	_	VBN	4	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
17	second	_	second	_	JJ	4	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
19	third	_	third	_	JJ	4	_	_	_	_	_	_	_	O
20	years	_	year	_	NNS	4	_	_	_	_	_	_	_	O
21	afterward	_	afterward	_	RB	4	_	_	_	_	_	_	_	O
22	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	4	_	_	_	_	_	_	_	O
2	reduction	_	reduction	_	NN	4	_	_	_	_	_	_	_	O
3	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
4	seen	_	see	_	VBN	4	_	_	_	_	_	_	_	O
5	immediately	_	immediately	_	RB	4	_	_	_	_	_	_	_	O
6	following	_	follow	_	VBG	4	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
8	launch	_	launch	_	NN	4	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	4	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
13	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
14	maintained	_	maintain	_	VBN	4	_	_	_	_	_	maintain.v	Activity_ongoing	O
15	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
17	second	_	second	_	JJ	4	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
19	third	_	third	_	JJ	4	_	_	_	_	_	_	_	O
20	years	_	year	_	NNS	4	_	_	_	_	_	_	_	O
21	afterward	_	afterward	_	RB	4	_	_	_	_	_	_	_	O
22	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	4	_	_	_	_	_	_	_	O
2	reduction	_	reduction	_	NN	4	_	_	_	_	_	_	_	O
3	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
4	seen	_	see	_	VBN	4	_	_	_	_	_	_	_	O
5	immediately	_	immediately	_	RB	4	_	_	_	_	_	_	_	O
6	following	_	follow	_	VBG	4	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
8	launch	_	launch	_	NN	4	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	4	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
13	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
14	maintained	_	maintain	_	VBN	4	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
17	second	_	second	_	JJ	4	_	_	_	_	_	second.a	Measure_duration	O
18	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
19	third	_	third	_	JJ	4	_	_	_	_	_	_	_	O
20	years	_	year	_	NNS	4	_	_	_	_	_	_	_	O
21	afterward	_	afterward	_	RB	4	_	_	_	_	_	_	_	O
22	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	4	_	_	_	_	_	_	_	O
2	reduction	_	reduction	_	NN	4	_	_	_	_	_	_	_	O
3	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
4	seen	_	see	_	VBN	4	_	_	_	_	_	_	_	O
5	immediately	_	immediately	_	RB	4	_	_	_	_	_	_	_	O
6	following	_	follow	_	VBG	4	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
8	launch	_	launch	_	NN	4	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
11	program	_	program	_	NN	4	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
13	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
14	maintained	_	maintain	_	VBN	4	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
17	second	_	second	_	JJ	4	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
19	third	_	third	_	JJ	4	_	_	_	_	_	_	_	O
20	years	_	year	_	NNS	4	_	_	_	_	_	year.n	Measure_duration	O
21	afterward	_	afterward	_	RB	4	_	_	_	_	_	_	_	O
22	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	effects	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	5	_	_	_	_	_	on.prep	Being_in_operation	O
3	overall	_	overall	_	JJ	5	_	_	_	_	_	_	_	O
4	opioid	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
5	prescribing	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
7	prescribing	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
10	analgesics	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
11	were	_	be	_	VBD	5	_	_	_	_	_	_	_	O
12	limited	_	limit	_	VBN	5	_	_	_	_	_	_	_	O
13	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	effects	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
3	overall	_	overall	_	JJ	5	_	_	_	_	_	_	_	O
4	opioid	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
5	prescribing	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
7	prescribing	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	5	_	_	_	_	_	of.prep	Age	O
9	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
10	analgesics	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
11	were	_	be	_	VBD	5	_	_	_	_	_	_	_	O
12	limited	_	limit	_	VBN	5	_	_	_	_	_	_	_	O
13	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	effects	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
3	overall	_	overall	_	JJ	5	_	_	_	_	_	_	_	O
4	opioid	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
5	prescribing	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
7	prescribing	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
10	analgesics	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
11	were	_	be	_	VBD	5	_	_	_	_	_	_	_	O
12	limited	_	limit	_	VBN	5	_	_	_	_	_	limit.v	Limitation	O
13	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	use.n	Ingest_substance	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	of.prep	Age	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	of.prep	Age	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	policy.n	Law	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	practice.n	Custom	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	use.n	Ingest_substance	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	may.v	Possibility	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	have.v	Possession	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	contribute.v	Giving	O
20	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	increased	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
2	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
4	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
5	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	adoption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
10	new	_	new	_	JJ	6	_	_	_	_	_	_	_	O
11	policies	_	policy	_	NNS	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	practices	_	practice	_	NNS	6	_	_	_	_	_	_	_	O
14	governing	_	govern	_	VBG	6	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	6	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
17	may	_	may	_	MD	6	_	_	_	_	_	_	_	O
18	have	_	have	_	VB	6	_	_	_	_	_	_	_	O
19	contributed	_	contribute	_	VBN	6	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	6	_	_	_	_	_	to.prep	Goal	O
21	sustained	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
22	effectiveness	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
23	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	future	_	Future	_	JJ	7	_	_	_	_	_	future.a	Temporal_collocation	O
2	studies	_	study	_	NNS	7	_	_	_	_	_	_	_	O
3	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
4	needed	_	need	_	VBN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	evaluate	_	UNK	_	VB	7	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
8	policies	_	policy	_	NNS	7	_	_	_	_	_	_	_	O
9	'	_	'	_	POS	7	_	_	_	_	_	_	_	O
10	comparative	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	effectiveness	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
12	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	future	_	Future	_	JJ	7	_	_	_	_	_	_	_	O
2	studies	_	study	_	NNS	7	_	_	_	_	_	_	_	O
3	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
4	needed	_	need	_	VBN	7	_	_	_	_	_	need.v	Required_event	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	evaluate	_	UNK	_	VB	7	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
8	policies	_	policy	_	NNS	7	_	_	_	_	_	_	_	O
9	'	_	'	_	POS	7	_	_	_	_	_	_	_	O
10	comparative	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	effectiveness	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
12	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	future	_	Future	_	JJ	7	_	_	_	_	_	_	_	O
2	studies	_	study	_	NNS	7	_	_	_	_	_	_	_	O
3	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
4	needed	_	need	_	VBN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	to.prep	Goal	O
6	evaluate	_	UNK	_	VB	7	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
8	policies	_	policy	_	NNS	7	_	_	_	_	_	_	_	O
9	'	_	'	_	POS	7	_	_	_	_	_	_	_	O
10	comparative	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	effectiveness	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
12	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	future	_	Future	_	JJ	7	_	_	_	_	_	_	_	O
2	studies	_	study	_	NNS	7	_	_	_	_	_	_	_	O
3	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
4	needed	_	need	_	VBN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	evaluate	_	UNK	_	VB	7	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
8	policies	_	policy	_	NNS	7	_	_	_	_	_	policy.n	Law	O
9	'	_	'	_	POS	7	_	_	_	_	_	_	_	O
10	comparative	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	effectiveness	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
12	.	_	.	_	.	7	_	_	_	_	_	_	_	O

